Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 212

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21

Blutt, Sarah E., McDonnell, Timothy J., Polek, Tara C., Weigel, Nancy L.·2000·Endocrinology

Abstract

While the role of vitamin D in bone and mineral metabolism has been investigated extensively, the role of the vitamin D receptor in other tissues is less well understood. 1,25-dihydroxyvitamin D3 (calcitriol) can act as a differentiating agent in normal tissues and can inhibit the growth of many cancer cell lines including LNCaP prostate cancer cells. We have shown previously that calcitriol causes LNCaP cell accumulation in the G0/G1 phase of the cell cycle. In this study, we demonstrate that calcitriol also induces apoptosis of LNCaP cells. The calcitriol-induced apoptosis is accompanied by a down-regulation of Bcl-2 and Bcl-XL proteins, both of which protect cells from undergoing apoptosis. Other proteins important in apoptotic control, Bax, Mcl-1, and Bcl-Xs, are unaffected by calcitriol treatment. We find that overexpression of Bcl-2 blocks calcitriol-induced apoptosis and reduces, but does not eliminate, calcitriol-induced growth inhibition. We conclude that both regulation of cell cycle and the apoptotic pathway are involved in calcitriol action in prostate cancer cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/endo.141.1.7289

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 51

  1. Carter, 1990, The prostate: an increasing medical problem., Prostate, 16, 39, 10.1002/pros.2990160105 · DOI · Paper page
  2. Carter, 1990, Epidemiologic evidence regarding predisposing factors to prostate cancer., Prostate, 16, 187, 10.1002/pros.2990160302 · DOI
  3. Pols, 1990, Vitamin D: a modulator of cell proliferation and differentiation., J Steroid Biochem Mol Biol, 37, 873, 10.1016/0960-0760(90)90435-N · DOI
  4. Giguere, 1994, Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling., Endocr Rev, 15, 61
  5. McDonnell, 1987, Molecular cloning of complementary DNA encoding the avian receptor for vitamin D., Science, 235, 1214, 10.1126/science.3029866 · DOI · Paper page
  6. Skowronski, 1993, Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines., Endocrinology, 132, 1952, 10.1210/endo.132.5.7682937 · doi:10.1210/endo.132.5.7682937
  7. Miller, 1995, Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1α, 25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines., Clin Cancer Res, 1, 997
  8. Hedlund, 1996, Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1α, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway., Endocrinology, 137, 1554, 10.1210/endo.137.5.8612485 · doi:10.1210/endo.137.5.8612485
  9. Hedlund, 1996, Vitamin D receptor expression is required for growth modulation by 1α,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31., J Steroid Biochem, 58, 277, 10.1016/0960-0760(96)00030-1 · doi:10.1016/0960-0760(96)00030-1
  10. Zhuang, 1997, Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines., Mol Cell Endocrinol, 126, 83, 10.1016/S0303-7207(96)03974-3 · doi:10.1016/s0303-7207(96)03974-3
  11. Blutt, 1997, 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1., Endocrinology, 138, 1491, 10.1210/endo.138.4.5063 · doi:10.1210/endo.138.4.5063 · Paper page
  12. Eisman, 1989, 1,25-dihydroxyvitamin D3 and the regulation of human cancer cell replication., Proc Soc Exp Biol Med, 191, 221, 10.3181/00379727-191-42912 · doi:10.3181/00379727-191-42912
  13. Simboli-Campbell, 1996, 1,25-dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells., J Steroid Biochem, 58, 367, 10.1016/0960-0760(96)00055-6 · DOI · Paper page
  14. Benassi, 1997, 1,25-dihydroxyvitamin D3, transforming growth factor β1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes., J Invest Dermatol, 109, 276, 10.1111/1523-1747.ep12335756 · DOI
  15. Vandewalle, 1995, Effects of vitamin D3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT29 cells: possible implication of intracellular calcium., Cancer Lett, 97, 99, 10.1016/0304-3835(95)03958-Y · doi:10.1016/0304-3835(95)03958-y
  16. James, 1996, Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells., Mol Biol, 58, 395
  17. Elstner, 1995, 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines., Cancer Res, 55, 2822
  18. Zhuang, 1998, Antiproliferative effect of 1α,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation., Endocrinology, 139, 1197, 10.1210/endo.139.3.5770 · DOI · Paper page
  19. Fife, 1997, Effects of vitamin D3 on proliferation of cancer cells in vitro., Cancer Lett, 120, 65, 10.1016/S0304-3835(97)00298-X · DOI
  20. Hsieh, 1997, Induction of apoptosis and altered nuclear/cytoplasmic distribution of the androgen receptor and prostate specific antigen by 1α,25-dihydroxyvitamin D3 in androgen-responsive LNCaP cells., Biochem Biophys Res Commun, 235, 539, 10.1006/bbrc.1997.6838 · doi:10.1006/bbrc.1997.6838
  21. McDonnell, 1996, Importance of the bcl-2 family in cell death regulation., Experientia, 52, 1008, 10.1007/BF01920110 · DOI
  22. Herrmann, 1996, Cell death signal transduction and bcl-2 function., Biochem Soc Trans, 24, 1059, 10.1042/bst0241059 · DOI
  23. Krajewska, 1996, Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancer., Am J Pathol, 148, 1567
  24. Gee, 1994, Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy., Int J Cancer, 59, 619, 10.1002/ijc.2910590508 · DOI · Paper page
  25. Ben-Ezra, 1994, Small cell carcinomas of the lung express the Bcl-2 protein., Am J Pathol, 145, 1036
  26. Carroll, 1993, p53 oncogene mutations in three human prostate cancer cell lines., Prostate, 23, 123, 10.1002/pros.2990230206 · DOI · Paper page
  27. Tilley, 1990, Androgen receptor gene expression in human prostate carcinoma cell lines., Cancer Res, 50, 5382
  28. Horoszewicz, 1983, LNCaP model of human prostatic carcinoma., Cancer Res, 43, 1809
  29. Bookstein, 1990, Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated Rb gene., Science, 247, 712, 10.1126/science.2300823 · DOI · Paper page
  30. MacGrogan, 1997, Tumour suppressor genes in prostate cancer., Semin Cancer Biol, 8, 11, 10.1006/scbi.1997.0048 · DOI
  31. Herrmann, 1997, Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells., Exp Cell Res, 234, 442, 10.1006/excr.1997.3653 · DOI
  32. Bcham, 1997, Bcl-2 inhibits p53 nuclear import following DNA damage., Oncogene, 15, 2767, 10.1038/sj.onc.1201464 · DOI
  33. Bradford, 1976, A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding., Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 · DOI · Paper page
  34. Gorczyca, 1993, Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays., Cancer Res, 53, 1945
  35. Day, 1994, Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells., Cell Growth Differ, 5, 735
  36. Liu, 1994, Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors., Mol Endocrinol, 8, 1593
  37. Raffo, 1997, Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo., Cancer Res, 55, 4438
  38. Kyprianou, 1997, Bcl-2 over-expression delays radiation-induced apoptosis without affecting clonogenic survival of human prostate cancer cells., J Cancer, 70, 341
  39. Gerdes, 1983, Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation., Int J Cancer, 31, 13, 10.1002/ijc.2910310104 · DOI · Paper page
  40. Skowronski, 1995, Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3., Endocrinology, 136, 20, 10.1210/endo.136.1.7530193 · doi:10.1210/endo.136.1.7530193
  41. Simboli-Campbell, 1997, Comparative effects of 1,25 (OH)2D3 and EB 1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells., Breast Cancer Res Treat, 42, 31, 10.1023/A:1005772432465 · doi:10.1023/a:1005772432465
  42. Xu, 1993, 1,25-dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene., Exp Cell Res, 209, 367, 10.1006/excr.1993.1322 · doi:10.1006/excr.1993.1322
  43. Hockenbery, 1990, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death., Nature, 348, 334, 10.1038/348334a0 · DOI · Paper page
  44. Schwartz, 1994, Human prostate cancer cells: inhibition of proliferation by vitamin D analogs., Anticancer Res, 14, 1077
  45. Kubota, 1998, 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells., Cancer Res, 58, 3370
  46. de Vos, 1997, Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines., Prostate, 31, 77, 10.1002/(SICI)1097-0045(19970501)31:2<77::AID-PROS1>3.0.CO;2-E · doi:10.1002/(sici)1097-0045(19970501)31:2<77::aid-pros1>3.0.co;2-e
  47. Ly, 1999, Liarozole acts synergistically with 1α,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity., Endocrinology, 140, 2071, 10.1210/endo.140.5.6698 · doi:10.1210/endo.140.5.6698
  48. Zhao, 1997, 1α,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent., Endocrinology, 138, 3290, 10.1210/endo.138.8.5328 · DOI
  49. Colombel, 1993, Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancer., Am J Pathol, 143, 390
  50. McDonnell, 1993, Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer., Am J Pathol, 143, 390
  51. Dorai, 1997, Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents., Anticancer Res, 17, 3307

Cited by

See all 212

Metadata

Authors
Blutt, S. E., McDonnell, T. J., Polek, T. C., & Weigel, N. L.
Venue
Endocrinology
Published
2000-01-01
Volume
141
Issue
1
Pages
10-17
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2101305429
Cited by
212
References
1
FWCI
5.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21. https://app.cochat.ai/papers/10.1210/endo.141.1.7289
The paper
Blutt, S. E., McDonnell, T. J., Polek, T. C., & Weigel, N. L. (2000). Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21. Endocrinology. https://doi.org/10.1210/endo.141.1.7289

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.